Sign Up Today and Learn More About Jnana Therapeutics Stock
Invest in or calculate the value of your shares in Jnana Therapeutics or other pre-IPO companies through EquityZen's platform.
Jnana Therapeutics Stock (JNTH)
Jnana Therapeutics is a biotechnology company that creates therapies that improve patients' lives.
About Jnana Therapeutics Stock
Founded
2017
Headquarters
Boston, MA, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Jnana Therapeutics Press Mentions
Stay in the know about the latest news on Jnana Therapeutics
Naphthyl-containing piperidine inhibitors of slc6a19 function
patents • Apr 02, 2025
Bicyclic heteroaryl-containing piperidine inhibitors of slc6a19 function
patents • Apr 02, 2025
Piperidine inhibitor of slc6a19 function
patents • Apr 02, 2025
Phenylketonuria Treatment Market Set to Surge at 7.8% CAGR, to Reach US$ 1.62 Billion by 2034: Fact.MR Report
einpresswire • Mar 20, 2025
Crystalline forms of a piperidine inhibitor of slc6a19 function
patents • Feb 08, 2025
Jnana Therapeutics Management
Leadership team at Jnana Therapeutics
Founder
Stuart L. Schreiber
Co-founder, President & CSO
Joel Barrish
Join now and verify your accreditation status to gain access to:
- Jnana Therapeutics Current Valuation
- Jnana Therapeutics Stock Price
- Jnana Therapeutics Management
- Available deals in Jnana Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Jnana Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Jnana Therapeutics Revenue and Financials
- Jnana Therapeutics Highlights
- Jnana Therapeutics Business Model
- Jnana Therapeutics Risk Factors
- Jnana Therapeutics Research Report from SACRA Research
Trading Jnana Therapeutics Stock
How to invest in Jnana Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Jnana Therapeutics through EquityZen funds. These investments are made available by existing Jnana Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Jnana Therapeutics stock?
Shareholders can sell their Jnana Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
